PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
62.10
Similar ESG score to ADAP's 62.68. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
59.34
Environmental score 1.1-1.2x ADAP's 55.73. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
63.14
Social score 90-95% of ADAP's 67.05. Bill Ackman would demand clear social improvement catalysts.
63.83
Similar governance score to ADAP's 65.25. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.